Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
The purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary clinical activity of M9140 in advanced solid tumors. Study details include: * Study Duration per participant: Approximately 4 months * M9140 is not available through an expanded access program
创建时间：
2022-08-15
